Citations

Showing 10 of 108119 citations.

Incidence, outcomes, and impact of COVID‐19 on inflammatory bowel disease: propensity matched research network analysis
Hadi, Yousaf , Dulai, Parambir S. , Mohy‐ud‐din, Nabeeha , Farraye, Francis A. , Kochhar, Gursimran , Farraye, Francis A , Kochhar, Gursimran S , Kupec, Justin Thomas , Jairath, Vipul

Mayo Clinic

Alimentary Pharmacology & Therapeutics | December 14, 2021 | Volume: 55 | Issue: 2 | Pages: 191-200

10.1111/apt.16730 | PMID 34904240 Get It

SummaryBackgroundAccurate estimates for the risk of COVID‐19 in IBD, and an understanding of the impact of COVID‐19 on IBD course and the risk of incident post‐infectious IBD are needed.AimsTo estimate the risk of COVID‐19 in IBD and study its impact on IBD course and the risk of incident post‐infectious IBD.MethodsA retrospective propensity score matched cohort study utilising multi‐institutional research network TriNetX. COVID‐19 patients with and without IBD were identified to quantify the risk of COVID‐19 in patients with IBD, COVID‐19 outcomes in patients with IBD and the impact of COVID‐19 on IBD disease course. The risk of incident post‐infectious IBD in COVID‐19 patients was compared to the population not infected with COVID‐19 during a similar time period.ResultsIncidence rate ratio for COVID‐19 was lower in IBD patients compared to the non‐IBD population (0.79, 95% CI: 0.72‐0.86). COVID‐19‐infected patients with IBD were at increased risk for requiring hospitalisation compared to non‐IBD population (RR: 1.17, 95% CI: 1.02‐1.34) with no differences in need for mechanical ventilation or mortality. Patients with IBD on steroids were at an increased risk for critical care need (RR: 2.22, 95% CI: 1.29‐3.82). Up to 7% of patients with IBD infected with COVID‐19 suffered an IBD flare 3‐months post‐infection. Risk for incident IBD post‐COVID was lower than that seen in the non‐COVID population (RR: 0.64, 95% CI: 0.54‐0.65).ConclusionWe observed no increase in risk for COVID‐19 amongst patients with IBD or risk for de novo IBD after COVID‐19 infection. We confirmed prior observations regarding the impact of steroid use on COVID‐19 severity in patients with IBD.
Skin Cancer Risk Perception and Tanning Bed Use: A Population-Based Survey to Identify Persons at Risk for Melanoma in Olmsted County, Minnesota
Barbosa, Naiara S., Yost, Kathleen J., Petterson, Tanya M., Mara, Kristin C., Brewer, Jerry D., Barbosa, Naiara S. , Mara, Kristin C. , Mara, Kristin C , Barbosa, Naiara S., Yost, Kathleen J., Petterson, Tanya M., Brewer, Jerry D.

Mayo Clinic

Dermatologic Surgery | December 14, 2021 | Volume: 48 | Issue: 1 | Pages: 34-38

10.1097/dss.0000000000003277 | PMID 34904576 Get It

BACKGROUND Cutaneous melanoma is strongly associated with tanning bed use. OBJECTIVE To describe local residents' knowledge, attitudes, and behavior regarding skin cancer and tanning bed use and to estimate prevalence of high risk for melanoma. MATERIALS AND METHODS A survey was mailed to 886 local residents (549, aged 18–39 years; 337, aged ≥40 years). Logistic and linear regression and univariate and multivariable analysis were used to assess perceived risk and skin cancer knowledge. RESULTS The response rate was 21%; 55% of the younger group and 37% of the older group had used indoor tanning, and prevalence of high risk for melanoma according to a skin cancer risk calculator was 18% in the younger group and 33% in the older group. Individuals with high risk scores were more likely to correctly perceive that they were at high risk for skin cancer. Most participants with high risk scores and those who previously used tanning beds reported low likelihood of future indoor tanning. CONCLUSION Female sex, high risk score, and previous indoor tanning were associated with participants' views of higher skin cancer risk. No specific knowledge gaps were identified. Understanding community residents' attitudes about skin cancer and indoor tanning can help guide interventions.
Prevalence of cerebral vein thrombosis among patients with spontaneous intracranial hypotension
Oien, Michael P , JK, Cutsforth-Gregory, Garza, Ivan , NR, Kissoon, CM, Carr, Brinjikji, Waleed , M, Oien , I, Garza, Brinjikji, Waleed , Cutsforth‐Gregory, Jeremy K. , Kissoon, Narayan

Mayo Clinic

Interventional Neuroradiology | December 14, 2021 | Volume: 28 | Issue: 6 | Pages: 719-725

10.1177/15910199211065912 | PMID 34904470 Get It

Background and purpose Cerebral venous sinus thrombosis (CVST) is a rare condition but an important complication of spontaneous intracranial hypotension (SIH). We reviewed our experience of patients with SIH and assessed for the presence of CVST. Methods We reviewed the medical records and imaging studies from our tertiary referral institution, assessing patients with clinically suspected SIH as well as imaging findings of intracranial hypotension. All relevant brain MRIs were reviewed for the presence of brain sag, pachymeningeal enhancement, and CVST. Results Among 563 patients with a clinical diagnosis of SIH, 431 (76%) demonstrated brain sag. In the overall patient cohort, a total of 5 patients had CVST (0.9%) and all 5 of these patients demonstrated findings of brain sag. Of the patients with CVST, 3 had significant complications, including dural arteriovenous fistulas (2 patients) and lobar hemorrhage with seizure (1 patient). Conclusion SIH is a risk factor for the development of CVST. In our review of 563 patients with clinical and/or imaging findings of SIH, 0.9% of patients were diagnosed with CVST and 3 of these patients (60%) had additional severe complications.
Behavioral and Physiologic Effects of Dirty Bedding Exposure in Female ICR Mice
Merley, Anne L, Hubbard, Jennifer, Rendahl, Aaron , Boynton, Felicia D. Duke , Impelluso, Lynn Collura, Duke Boynton, Felicia D

Mayo Clinic

Journal of the American Association for Laboratory Animal Science | December 14, 2021 | Volume: 61 | Issue: 1 | Pages: 42-51

10.30802/aalas-jaalas-21-000060 | PMID 34903313 Get It

Exposure of sentinel mice to dirty bedding is commonly used in health monitoring programs to screen colonies for clinical and subclinical disease. Despite the potential stressors present in dirty bedding, including but not limited to microorganisms, pheromones, and ammonia, it is unknown whether sentinel mice exposed to soiled bedding experience stress. In this study, select behavioral and physiologic changes associated with stress were assessed in female ICR mice exposed to dirty bedding. Behavioral parameters included evaluation in the home cage and selected behavioral tests; physiologic measurements included neutrophil:lymphocyte ratio and weight. Mice in the acute group were exposed for 24 h whereas mice in the chronic group were exposed for 4 wk. Mice in the chronic group exposed to dirty bedding weighed less at days 21 and 28 than did control mice. Chronic mice exposed to dirty bedding also exhibited decreased net weight gain over the entire study period as compared with control mice. No significant differences were detected in the other behavioral and physiologic parameters measured. These results indicate that dirty bedding exposure may affect sentinel mice, but further investigation is needed to determine the specific mechanism(s) behind the weight difference.
Comment: Introducing Neurologic Therapeutics in 2035
Gross, Robert A., Jones, Lyell K , Gross, Robert A.

Mayo Clinic

Neurology | December 13, 2021 | Volume: 97 | Issue: 24 | Pages: 1120-1120

10.1212/wnl.0000000000012977 | PMID 34903612 Get It

Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post‐acute sequelae of SARS‐CoV‐2 infection (PASC)
Fine, Jeffrey S., Ambrose, Anne Felicia , Fleming, Talya K. , Glashan, Lissette, Longo, Michele, Merlino, Alexandra, Ng, Rowena , Nora, Gerald J. , Rolin, Summer , Terzic, Carmen M., Sampsel, Sarah , Fleming, Talya K , Ng, Rowena , Silver, Julie , Verduzco-Gutierrez, Monica , Sampsel, Sarah , Didehbani, Nyaz , Silver, Julie K. , Verduzco‐Gutierrez, Monica

Mayo Clinic

PM&R | December 13, 2021 | Volume: 14 | Issue: 1 | Pages: 96-111

10.1002/pmrj.12745 | PMID 34902226 Get It

Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
Pottier, Cyril , Mateiu, Ligia , DeJesus‐Hernandez, Mariely, Vicente, Cristina T. , Finch, NiCole A., Tian, Shulan , Blitterswijk, Marka van , Ren, Yingxue , Petrucelli, Leonard , Oskarsson, Björn , Graff‐Radford, Neill R. , Petersen, Ronald C. , Josephs, Keith A. , Asmann, Yan W. , Rademakers, Rosa , Baker, Matthew C, DeJesus-Hernandez, Mariely, van Blitterswijk, Marka , Oskarsson, Björn , Boeve, Brad , Josephs, Keith A , Dickson, Dennis W , Murray, Melissa E , Pottier, Cyril , Baker, Matthew , Murray, Melissa E. , Biernacka, Joanna M. , Boeve, Bradley F. , Dickson, Dennis W.

Mayo Clinic

Brain | December 13, 2021 | Volume: 145 | Issue: 7 | Pages: 2472-2485

10.1093/brain/awab437 | PMID 34918030 Get It

Abstract Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is a complex heterogeneous neurodegenerative disorder for which mechanisms are poorly understood. To explore transcriptional changes underlying FTLD-TDP, we performed RNA-sequencing on 66 genetically unexplained FTLD-TDP patients, 24 FTLD-TDP patients with GRN mutations and 24 control participants. Using principal component analysis, hierarchical clustering, differential expression and coexpression network analyses, we showed that GRN mutation carriers and FTLD-TDP-A patients without a known mutation shared a common transcriptional signature that is independent of GRN loss-of-function. After combining both groups, differential expression as compared to the control group and coexpression analyses revealed alteration of processes related to immune response, synaptic transmission, RNA metabolism, angiogenesis and vesicle-mediated transport. Deconvolution of the data highlighted strong cellular alterations that were similar in FTLD-TDP-A and GRN mutation carriers with NSF as a potentially important player in both groups. We propose several potentially druggable pathways such as the GABAergic, GDNF and sphingolipid pathways. Our findings underline new disease mechanisms and strongly suggest that affected pathways in GRN mutation carriers extend beyond GRN and contribute to genetically unexplained forms of FTLD-TDP-A.
A New Gene Set Identifies Senescent Cells and Predicts Senescence-Associated Pathways Across Tissues
Khosla, Sundeep , Saul, Dominik , Kosinsky, Robyn Laura , Atkinson, Elizabeth J. , LeBrasseur, Nathan K. , Pignolo, Robert J. , Robbins, Paul D. , Niedernhofer, Laura J. , Ikeno, Yuji , Jurk, Diana , Xue, Ailing, Kirkland, James L. , Khosla, Sundeep , Jurk, Diana , LeBrasseur, Nathan K , Niedernhofer, Laura J , Robbins, Paul D , Kosinsky, Robyn Laura , Saul, Dominik , Doolittle, Madison L. , Zhang, Xu , Passos, João F. , Hickson, LaTonya J. , Monroe, David G. , Tchkonia, Tamar , Farr, Joshua N.

Mayo Clinic

No container title available | December 13, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1034608/v1 Get It

Abstract Although cellular senescence is increasingly recognized as driving multiple age-related co-morbidities through the senescence-associated secretory phenotype (SASP), in vivo senescent cell identification, particularly in bulk or single cell RNA-sequencing (scRNA-seq) data remains challenging. Here, we generated a novel gene set (SenMayo) and first validated its enrichment in bone biopsies from two aged human cohorts. SenMayo also identified senescent cells in aged murine brain tissue, demonstrating applicability across tissues and species. For direct validation, we demonstrated significant reductions in SenMayo in bone following genetic clearance of senescent cells in mice, with similar findings in adipose tissue from humans in a pilot study of pharmacological senescent cell clearance. In direct comparisons, SenMayo outperformed all six existing senescence/SASP gene sets in identifying senescent cells across tissues and in demonstrating responses to senescent cell clearance. We next used SenMayo to identify senescent hematopoietic or mesenchymal cells at the single cell level from publicly available human and murine bone marrow/bone scRNA-seq data and identified monocytic and osteolineage cells, respectively, as showing the highest levels of senescence/SASP genes. Using pseudotime and cellular communication patterns, we found senescent hematopoietic and mesenchymal cells communicated with other cells through common pathways, including the Macrophage Migration Inhibitory Factor (MIF) pathway, which has been implicated not only in inflammation but also in immune evasion, an important property of senescent cells. Thus, SenMayo identifies senescent cells across tissues and species with high fidelity. Moreover, using this senescence panel, we were able to characterize senescent cells at the single cell level and identify key intercellular signaling pathways associated with these cells, which may be particularly useful for evolving efforts to map senescent cells (e.g., SenNet). In addition, SenMayo represents a potentially clinically applicable panel for monitoring senescent cell burden with aging and other conditions as well as in studies of senolytic drugs.
Role of Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer
Yu, Nathan Y. , Ernani, Vinicius , Savvides, P. , Sio, Terence T. , Schild, Steven E.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | December 13, 2021 | Volume: 19 | Issue: 12 | Pages: 1465-1469

10.6004/jnccn.2021.7105 | PMID 34902829 Get It

Patients with small cell lung cancer (SCLC) are at significant risk of developing brain metastases during their disease course. Prophylactic cranial irradiation (PCI) has been incorporated into SCLC treatment guidelines to diminish the risk of developing brain metastases. In 2007, a randomized trial suggested that PCI decreases the incidence of brain metastases and prolongs overall survival (OS) in patients with extensive-stage SCLC (ES-SCLC) who have responded to initial therapy. However, this study did not include modern central nervous system imaging with CT or MRI prior to randomization. A more recent Japanese trial with MRI staging and surveillance demonstrated that PCI diminished the incidence of brain metastases but did not improve survival. This review examines the largest clinical studies, controversies, and future directions of PCI in patients with ES-SCLC.